Atlas Venture Advisors, Inc. Long-Term Concentrated

CIK: 0001767432 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 7, 2020

Total Value ($000): $73,859 (100.0% shares, 0.0% debt)

Holdings (7)

— TRANSLATE BIO INC 52.9%

Value ($000) $39,102 Shares 3,922,008 Est. Cost $7.50 Unrealized —

BCYC BICYCLE THERAPEUTICS PLC 25.2%

Value ($000) $18,601 Shares 1,362,696 Est. Cost $10.06 Unrealized —

ROKU ROKU INC 6.8%

Value ($000) $5,048 Shares 57,707 Est. Cost $137.43 Unrealized -16.2%

DDOG DATADOG INC 5.5%

Value ($000) $4,074 Shares 113,232 Est. Cost $34.77 Unrealized +18.5%

SNAP SNAP INC 4.0%

Value ($000) $2,920 Shares 245,559 Est. Cost $6.50 Unrealized +136.0%

— ZAFGEN INC 3.7%

Value ($000) $2,700 Shares 3,506,207 Est. Cost $4.95 Unrealized —

— MIRAGEN THERAPEUTICS INC 1.9%

Value ($000) $1,414 Shares 3,142,580 Est. Cost $3.03 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	TRANSLATE BIO INC	3,922,008	$39,102	52.9%	$7.50	—	COM	89374L104
BCYC	BICYCLE THERAPEUTICS PLC	1,362,696	$18,601	25.2%	$10.06	—	SPONSORED ADS	088786108
ROKU	ROKU INC	57,707	$5,048	6.8%	$137.43	-16.2%	COM CL A	77543R102
DDOG	DATADOG INC	113,232	$4,074	5.5%	$34.77	+18.5%	CL A COM	23804L103
SNAP	SNAP INC	245,559	$2,920	4.0%	$6.50	+136.0%	CL A	83304A106
—	ZAFGEN INC	3,506,207	$2,700	3.7%	$4.95	—	COM	98885E103
—	MIRAGEN THERAPEUTICS INC	3,142,580	$1,414	1.9%	$3.03	—	COM	60463E103